The Discounted Cash Flow (DCF) valuation of Rigel Pharmaceuticals Inc (RIGL) is 91.15 USD. With the latest stock price at 27.53 USD, the upside of Rigel Pharmaceuticals Inc based on DCF is 231.1%.
Based on the latest price of 27.53 USD and our DCF valuation, Rigel Pharmaceuticals Inc (RIGL) is a buy. buying RIGL stocks now will result in a potential gain of 231.1%.
| Range | Selected | |
| WACC / Discount Rate | 7.4% - 11.0% | 9.2% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 73.10 - 122.00 | 91.15 |
| Upside | 165.5% - 343.1% | 231.1% |